Physician profile
Daniel J Devries
NPI 1073558029
$741.30
in general payments reported to CMS, 2019-2025
10 companies · $97.93 in 2025
The $97.93 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $105 · 2022: $39.56 · 2025: $97.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $189.03 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $120.39 | 2019-2025 | Rexulti |
| Lundbeck LLC | $111.51 | 2019-2025 | Rexulti |
| Sunovion Pharmaceuticals INC. | $95.90 | 2019 | |
| Alkermes, INC. | $62.54 | 2022-2025 | Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $53.53 | 2019-2020 | |
| Shire North American Group INC | $42.46 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $29.56 | 2019 | |
| Vanda Pharmaceuticals INC. | $20.01 | 2019 | |
| Allergan, INC. | $16.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Devries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.